Microenvironment and Biomarkers in Esophageal Cancers: An Approach for Early Detection and Identification
2024

Biomarkers for Early Detection of Esophageal Cancers

Sample size: 104 publication Evidence: high

Author Information

Author(s): Muacevic Alexander, Adler John R, Eltahir Zakaria, Eisa Alaa A, Keayta Mohamed H, Aljhani Yousif A, Alfaroqui Omar, Jenkins Gareth J

Primary Institution: College of Applied Medical Sciences, Department of Clinical Laboratory Sciences, Taibah University, Medina, SAU

Hypothesis

This study aims to investigate potential histological biomarkers for esophageal adenocarcinoma (EAC) to facilitate early and accurate identification of histological changes, especially in patients with GERD.

Conclusion

The study highlights the significance of the P63 marker in distinguishing between esophageal squamous cell carcinoma (ESCC) and EAC, suggesting its potential role in early detection.

Supporting Evidence

  • The study analyzed 104 esophageal biopsy samples, including 79 diagnosed with EAC.
  • 86 cases showed negative P63 staining, confirming their origin from non-squamous cells.
  • Five of the 13 SCC control cases exhibited P63 positivity, demonstrating a highly significant association.
  • Masson’s trichrome staining revealed stromal collagen fibers infiltrating the malignant tissue areas.

Takeaway

Researchers looked at tissue samples to find markers that help tell two types of esophageal cancer apart, which could help catch the disease early.

Methodology

This cross-sectional study examined archival histological samples from patients with lower esophageal abnormalities using immunohistochemistry and Masson’s trichrome stain.

Limitations

The study's limitations include a small sample size and incomplete demographic data.

Statistical Information

P-Value

<0.00001

Statistical Significance

p<0.00001

Digital Object Identifier (DOI)

10.7759/cureus.74242

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication